Boston Scientific Looking To Expand Urology/Gynecology Product Offerings
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific remains open to the possibility of making an acquisition in the urology or gynecology area to boost the current 8-10% rate of revenue growth.